Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation
2012; Springer Nature; Volume: 31; Issue: 14 Linguagem: Inglês
10.1038/emboj.2012.156
ISSN1460-2075
AutoresAnastasia Kosenko, Seungwoo Kang, Ida M. Smith, Derek L. Greene, Lorene K. Langeberg, John D. Scott, Naoto Hoshi,
Tópico(s)Cardiac electrophysiology and arrhythmias
ResumoArticle29 May 2012free access Source Data Coordinated signal integration at the M-type potassium channel upon muscarinic stimulation Anastasia Kosenko Anastasia Kosenko Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Seungwoo Kang Seungwoo Kang Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Ida M Smith Ida M Smith Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Derek L Greene Derek L Greene Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Lorene K Langeberg Lorene K Langeberg Department of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA Search for more papers by this author John D Scott John D Scott Department of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA Search for more papers by this author Naoto Hoshi Corresponding Author Naoto Hoshi Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Anastasia Kosenko Anastasia Kosenko Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Seungwoo Kang Seungwoo Kang Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Ida M Smith Ida M Smith Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Derek L Greene Derek L Greene Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Lorene K Langeberg Lorene K Langeberg Department of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA Search for more papers by this author John D Scott John D Scott Department of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA Search for more papers by this author Naoto Hoshi Corresponding Author Naoto Hoshi Department of Pharmacology, University of California, Irvine, CA, USA Search for more papers by this author Author Information Anastasia Kosenko1, Seungwoo Kang1, Ida M Smith1, Derek L Greene1, Lorene K Langeberg2, John D Scott2 and Naoto Hoshi 1 1Department of Pharmacology, University of California, Irvine, CA, USA 2Department of Pharmacology, Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA *Corresponding author. Department of Pharmacology, University of California, Irvine, 360 Med Surge II, Irvine, CA 92697, USA. Tel.:+1 949 824 0969; Fax:+1 949 824 4855; E-mail: [email protected] The EMBO Journal (2012)31:3147-3156https://doi.org/10.1038/emboj.2012.156 PDFDownload PDF of article text and main figures. Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Several neurotransmitters, including acetylcholine, regulate neuronal tone by suppressing a non-inactivating low-threshold voltage-gated potassium current generated by the M-channel. Agonist dependent control of the M-channel is mediated by calmodulin, activation of anchored protein kinase C (PKC), and depletion of the phospholipid messenger phosphatidylinositol 4,5-bisphosphate (PIP2). In this report, we show how this trio of second messenger responsive events acts synergistically and in a stepwise manner to suppress activity of the M-current. PKC phosphorylation of the KCNQ2 channel subunit induces dissociation of calmodulin from the M-channel complex. The calmodulin-deficient channel has a reduced affinity towards PIP2. This pathway enhances the effect of concomitant reduction of PIP2, which leads to disruption of the M-channel function. These findings clarify how a common lipid cofactor, such as PIP2, can selectively regulate ion channels. Introduction The M-current is generated by a group of low-threshold voltage-gated potassium channels encoded by the KCNQ gene family (KCNQ2, 3, 4, and 5) (Jentsch, 2000; Delmas and Brown, 2005). These subunits form heteromeric M-channels that control neuronal excitability and firing frequency. Accordingly, mutations in KCNQ genes underlie congenital excitatory neuropathological conditions and epilepsies including benign familial neonatal convulsions (Cooper and Jan, 1999; Jentsch, 2000). M-channels set the tone for neuronal activity. They generate the medium after-hyperpolarization currents that regulate intervals of neuronal firing (Peters et al, 2005). In fact, the M-channel can be considered to function as a band pass filter (Hu et al, 2009) as it optimizes the most effective frequency for neuronal reactivity to the theta frequency (6–10 Hz). This particular frequency of neuronal activity is important for inducing long-term potentiation, and is therefore critical for learning and memory (Buzsaki, 2002). In addition, activation at a near resting membrane potential counteracts the accumulation of excitatory postsynaptic potentials (Delmas and Brown, 2005; George et al, 2009; Shah et al, 2011), which triggers firing of action potentials at the axon initial segment where M-channels are clustered (Pan et al, 2006; Shah et al, 2008). Various neurotransmitters annul M-currents to lower the threshold for action potential firing (Marrion, 1997). A classic example of this is the action of acetylcholine (Brown and Adams, 1980). Stimulation of the m1 muscarinic acetylcholine receptor activates phospholipase C (PLC): an enzyme that catalyses the breakdown of PIP2 to generate diacylglycerol (DAG) and inositol trisphosphate. This combination of second messengers activates protein kinase C (PKC) and increases cytosolic calcium, respectively. Although each effector acts through a distinct mechanism, each of these PLC-mediated signalling events is sufficient to suppress the M-current (Gamper and Shapiro, 2003; Hoshi et al, 2003; Suh et al, 2006). For example, PIP2 has been identified as an essential cofactor for the M-channel function. Thus, depletion of PIP2 induced by PLC activation can suppress the M-current (Suh and Hille, 2002; Zhang et al, 2003; Winks et al, 2005). Local activation of PKC is required for muscarinic suppression of the M-current (Hoshi et al, 2005) and is controlled by the kinase anchoring protein, AKAP79/150 (Hoshi et al, 2003). Likewise, the release of calmodulin from the M-channel complex has been demonstrated to reduce the M-current (Yus-Najera et al, 2002; Shahidullah et al, 2005). Interestingly, all these candidate molecules: PIP2, AKAP79/150 and calmodulin, bind in close proximity to each other at the C-terminal tail of the M-channel as a macromolecular complex (Yus-Najera et al, 2002; Hoshi et al, 2003; Zhang et al, 2003; Delmas and Brown, 2005; Hernandez et al, 2008). Hence, there is reason to suspect synergistic regulation by these second messengers or effector proteins. However, the molecular interplay between these cofactors is not well understood. In this report, we demonstrate that PKC phosphorylation of the KCNQ2 subunit drives dissociation of calmodulin from the cytoplasmic tail of the channel. Consequently, the KCNQ2 subunit has both lower affinity for PIP2 and a reduced channel activity. Hence, the sequential and synergistic coupling of these factors specifies how ubiquitous signalling molecules such as PIP2 can be organized to selectively modulate the M-current. Results PKC phosphorylation at serine 541 of KCNQ2 sensitizes the muscarinic suppression of the KCNQ2 channel M-currents were recorded from rat superior cervical ganglion (SCG) neurons using perforated patch technique. The M-current was suppressed by the application of a muscarinic agonist, oxotremorine-M (oxo-M) (Figure 1A and B; 61±4% at t=1 min, n=14). This muscarinic suppression was attenuated by bisindolylmaleimide IV (BIS IV) (Figure 1A and B; 79±5%, n=13), which we have previously shown to be an effective inhibitor of PKC when it is anchored to the channel via AKAP79/150 (Hoshi et al, 2010). Further support for involvement of PKC phosphorylation of KCNQ2 subunits was provided by analysis of KCNQ2 subunits with mutations at S541, a previously identified PKC phosphorylation site (Hoshi et al, 2003). Two mutations were produced: an alanine substitution of S541, KCNQ2 (S541A), which lacks an acceptor for PKC phosphorylation, and an aspartate substitution, KCNQ2 (S541D), which mimics phosphorylation. The oxo-M responses of these KCNQ2 channels were measured in transiently transfected Chinese hamster ovary cells that stably express human muscarinic m1 receptor, CHO hm1 cells (Figure 1C and D). The KCNQ2 (S541A) channel exhibited a reduced response to oxo-M (82.7±2.7%, n=9). Subsequent application of BIS IV had no additional effect on the muscarinic suppression of this current (83.4±3.6%, n=11, P=0.88). This is consistent with the removal of a functionally relevant target substrate for PKC. In contrast, recordings of KCNQ2 (S541D) mutant channels exhibited more pronounced suppression when compared with the wild-type channel (Figure 1D; n=9). These results support the hypothesis that PKC phosphorylation sensitizes muscarinic suppression. Figure 1.PKC activation sensitizes muscarinic suppression of the M-current via phosphorylation of S541 of KCNQ2 subunit. (A, B) Perforated patch-clamp recordings from rat SCG neurons showing muscarinic suppression of the M-current induced by 0.1 μM oxo-M is attenuated by 10 μM bisindolylmaleimide IV (BIS IV). (A) Current traces showing M-current suppression induced by oxo-M and its attenuation by BIS IV. (B) Pooled data showing muscarinic suppression of the M-current. Amplitudes of the M-currents are normalized to those at t=0. The black box indicates the presence of oxo-M. (C, D) Whole-cell patch-clamp recordings from transiently transfected CHO hm1 cells showing muscarinic suppression of wild-type KCNQ2 and its S541 mutants induced by 0.1 μM oxo-M. (C) Current traces for KCNQ2 channels and their muscarinic suppressions. (D) Pooled data showing oxo-M responses of wild-type KCNQ2, KCNQ2 (S541A), and KCNQ2 (S541D). Amplitudes of the KCNQ2 currents are normalized to those at t=0. (E) Current densities of wild-type KCNQ2, KCNQ2 (S541A), and KCNQ2 (S541D). *<0.05, ***<0.001 calculated by nonparametric ANOVA followed by t-test. (F) Cell surface biotin labelling of wild-type KCNQ2, KCNQ (S541A), and KCNQ2 (S541D) (top panels), and of cytosolic GFP (lower panels). A representative blot from four independent experiments is shown. Error bars indicate s.e.m. Figure source data can be found with the Supplementary data. Download figure Download PowerPoint Furthermore, current densities were increased in cells expressing KCNQ2 (S541A) when compared with cells expressing the wild-type channel (Figure 1E; n=42 and n=32, respectively). In contrast, KCNQ2 (S541D) displayed reduced current density (Figure 1E; n=45). Since some KCNQ2 mutants undergo abnormal membrane trafficking (Jentsch, 2000; Etxeberria et al, 2008), the surface protein amounts of these KCNQ2 variants were validated by extracellular biotin labelling assays. All three versions of KCNQ2 channels showed equivalent biotinylation when expressed in CHO hm1 cells (Figure 1F; n=4). Immunoblots of KCNQ2 usually showed two bands, a sharp and faint 75 kDa band and a fuzzy 100 kDa band, which would correspond to unglycosylated and glycosylated KCNQ2 proteins respectively. The absence of biotinylation on a cytosolic marker protein, GFP, confirmed specificity of this surface labelling (Figure 1F, lower panel). Thus, the difference in current densities of these KCNQ2 mutants in CHO hm1 cells can be attributed to channel activity rather than the differences in the trafficking rates of the mutant channels. These results support the idea that the charge of S541 is key for channel activity. PKC phosphorylation disrupts KCNQ2–calmodulin binding Serine 541 is located in a distal segment of the two calmodulin-binding sites within cytoplasmic tail of the KCNQ2 subunit (Yus-Najera et al, 2002). Therefore, we reasoned that phosphorylation of this residue influences calmodulin binding. To test this hypothesis, we first performed immunoprecipitation of flag epitope-tagged wild-type or mutant KCNQ2 from cells cotransfected with V5 epitope-tagged calmodulin (Figure 2A) in a calcium-free condition. Immunoblot detection revealed that equivalent amounts of calmodulin coprecipitated with wild-type and KCNQ2 (S541A) proteins (Figure 2A, lanes 2 and 3). Conversely, a negligible amount of calmodulin was detected in KCNQ2 (S541D) immune complexes (Figure 2A, lane 4; n=5). This suggests that phosphorylation of S541 may interfere with calmodulin binding. To test this directly, we performed an in-vitro phosphorylation using purified PKC and KCNQ2 prior to the calmodulin-binding assay (Figure 2B). KCNQ2–flag subunits were pulled down using anti-flag-conjugated beads and washed at high stringency. These KCNQ2-beads were then either left untreated, phosphorylated by purified PKC, or dephosphorylated by λ protein phosphatase. The incorporation of 32P confirmed phosphorylation of the KCNQ2 protein (Figure 2B, middle blot, lane 2). The treated KCNQ2-beads were tested for calmodulin binding. CaM-V5 was used for this binding assay since it avoided detection of residual endogenous calmodulin that could remain during the KCNQ2 purification procedure. The PKC-phosphorylated KCNQ2 subunit bound a negligible amount of calmodulin (Figure 2B, lane 2; n=6) compared with untreated KCNQ2 controls (Figure 2B, lane 1; n=6). In contrast, calmodulin binding to the dephosphorylated KCNQ2 protein was robust and comparable to the untreated protein (Figure 2B, lane 3; n=6). Thus, PKC phosphorylation disrupts the KCNQ2–calmodulin interaction. Figure 2.PKC phosphorylation interferes with KCNQ2–calmodulin interaction. (A) Calmodulin binding to KCNQ2 protein and its PKC site mutants. ***<0.001 by nonparametric ANOVA followed by Dunn's multiple comparisons test. (B) In-vitro phosphorylation of KCNQ2 protein by purified PKCα and its calmodulin binding capability. Phosphorylated KCNQ2 protein cannot bind calmodulin. Calmodulin binding of untreated control and dephosphorylated KCNQ2 are also shown. ***<0.001 by nonparametric ANOVA followed by Dunn's multiple comparisons test. (C) Oxo-M treatment reduced calmodulin binding to KCNQ2. *<0.05 by paired t-test. Error bars indicate s.e.m. Figure source data can be found with the Supplementary data. Download figure Download PowerPoint Next, we examined whether release of calmodulin from KCNQ2 subunits can be induced upon muscarinic receptor stimulation. CHO hm1 cells coexpressing KCNQ2–flag and CaM-V5 were treated with 3 μM oxo-M for 3 min. The KCNQ2 immune complexes were tested for calmodulin binding by immunoblot with V5 antibodies. As expected, oxo-M treatment decreased the coprecipitated calmodulin (Figure 2C; n=4). To further examine whether muscarinic stimulation favours the dissociation of calmodulin from KCNQ channels in living cells, we performed intermolecular fluorescent resonance energy transfer (FRET) analyses (Figure 3). The FRET donor was monomeric cerulean, a brighter version of CFP (Shaner et al, 2005), tagged calmodulin (CaM–CFP). The FRET acceptor was monomeric citrine, a brighter version of YFP (Shaner et al, 2005), fused to KCNQ2 (KCNQ2–YFP). Fluorescent signals in the vicinity of the plasma membrane were detected by total internal reflection fluorescence (TIRF) microscopy (Steyer and Almers, 2001). These measurements revealed a higher FRET efficiency from the wild-type KCNQ2 (wt)–YFP and CaM–CFP pair over the control pair of KCNQ2 (wt)–YFP and CFP alone (Figure 3A and B; n=96 cells, n=92 cells, respectively). KCNQ2 (S541A) and CaM–CFP pair showed equivalent FRET signals to that of the wild-type pair (Figure 3A, middle; 104±8.2% of wild-type, n=101). Importantly, a lower FRET efficiency was measured with the KCNQ2 (S541D)–YFP and CaM–CFP pair compared with wild-type KCNQ2–YFP (Figure 3A, right; 68.2±9.8% of wild-type, n=123, P<0.0001). However, it is worthwhile to mention that the KCNQ2 (S541D) mutation weakened but did not completely eliminate the KCNQ2–calmodulin association since FRET efficiency with the CaM–CFP donor was elevated over that with the CFP donor alone (Figure 3A, right; n=98). Figure 3.Muscarinic stimulation induces dissociation of calmodulin from the KCNQ2 channel complex in living cells. (A) Pooled FRET efficiencies. Increased FRET efficiencies were observed in the wild-type KCNQ2–YFP (Q2 (wt)–YFP) and calmodulin–CFP (CaM–CFP) pair over the control pair, KCNQ2–YFP and CFP alone. KCNQ2 (S541A)–YFP (Q2 (S541A)–YFP) and CaM–CFP pair showed equivalent FRET efficiency to the wild-type pair. KCNQ2 (S541D)–YFP (Q2 (S541D)–YFP) and CaM–CFP showed reduced FRET efficiency compared with that from the wild-type pair, but showed significant FRET efficiency over the CFP control. N indicates numbers of cells observed. ***<0.001 by nonparametric ANOVA followed by t-test. (B, C) Schematic representations of KCNQ2–YFP and calmodulin–CFP interaction in control (B) and oxo-M applied condition (C). (D) Fluorescent images from CHO hm1 cells coexpressing KCNQ2–YFP and CaM–CFP. (E) Pseudocolour images of the cells shown in (D) showing decrease in FRET efficiency after 3 μM oxo-M application. (F) Changes in FRET efficiencies of KCNQ2–YFP and CaM–CFP upon 3 μM oxo-M application. FRET efficiency of the wild-type KCNQ2–YFP+CaM–CFP (Q2 (wt), blue circles) was decreased upon stimulation with oxo-M. Pretreatment with BIS IV attenuated oxo-M responses (Q2 (wt) BIS IV, black circles). KCNQ2 (S541A)+CaM–CFP pair showed similar attenuated responses (Q2 (S541A), green circles). The black box indicates the presence of oxo-M. Error bars indicate s.e.m. Download figure Download PowerPoint Application of the muscarinic agonist oxo-M also lowered the FRET efficiency for the KCNQ2–YFP+CaM–CFP pair (Figure 3B–F; n=96, P<0.0001). Since our coimmunoprecipitation experiments indicated that less KCNQ2 subunit bound CaM after oxo-M treatment (Figure 2C), we reasoned that the oxo-M responsive decrease in FRET signal was due to dissociation of CaM rather than change in dipole orientation. We next examined PKC involvement in calmodulin dissociation by suppressing PKC phosphorylation either by treating cells with BIS IV or by using KCNQ2 (S541A). Oxo-M induced FRET responses were suppressed to a similar degree in both KCNQ2 (S541A)–YFP+CaM–CFP (Figure 3F, green circles; n=78, P<0.01 at t=2 min) and BIS IV treated KCNQ2–YFP+CaM–YFP (Figure 3F, black circles; n=121, P<0.01 at t=2 min) compared with control responses (Figure 3F). These results imply that PKC phosphorylation of KCNQ2 induces dissociation of calmodulin in living cells. Stable KCNQ2–calmodulin association is required for maintaining PIP2 affinity Residues involved in PIP2 binding are scattered around the calmodulin-binding domains. One residue, histidine 328 (Zhang et al, 2003), locates within the proximal segment of the calmodulin-binding site (residues 310–451 of the channel (Yus-Najera et al, 2002)). A cationic cluster domain, which is sandwiched between the two calmodulin-binding sites, provides an additional PIP2-binding domain (Hernandez et al, 2008). The location of these functional modules implies that calmodulin binding might affect PIP2–KCNQ2 interaction. To test this and in order to estimate the affinity of PIP2 for KCNQ2, we utilized neomycin, which is widely used to sequester PIP2 (Liscovitch et al, 1994; Haider et al, 2007; Suh and Hille, 2007). The inclusion of 300 μM neomycin in the patch pipette solution promoted a sustained decrease in the KCNQ2 current over a 10-min time course (Figure 4A and B; n=10). Neomycin-induced rundown of the KCNQ2 current was prevented by inclusion of the water-soluble PIP2 analogues, 500 μM diC4-PIP2 or 500 μM diC8-PIP2, in the pipette solution. (Figure 4B and D; n=10). Additional control experiments confirmed that extracellular application of 1 mM neomycin for 10 min had no effect on the KCNQ2 current (Figure 4C; n=13). This allowed us to conclude that neomycin sequesters PIP2 from the intracellular side of the plasma membrane. Furthermore, in some channels such as Kir2.1, the carbon chain of diC4-PIP2 is too short to maintain channel function (Rohacs et al, 1999). Our results suggest that KCNQ2 channel is less selective for acyl chain requirements (Figure 4D). This view is consistent with recent findings that KCNQ1 channel can be facilitated by diC4-PIP2 (Li et al, 2011) and that KCNQ2 channel activity is enhanced by a variety of negatively charged lipids (Telezhkin et al, 2012). Figure 4.KCNQ2–calmodulin interaction determines PIP2 affinity of KCNQ2 channel. (A, B) Neomycin-induced rundown of KCNQ2 current and its prevention by diC4-PIP2. Current traces (A) and pooled data (B) show neomycin-induced rundown of KCNQ2 current (blue circles). This rundown was prevented by further addition of diC4-PIP2 in the patch pipette solution (green circles). KCNQ2 currents were normalized to KCNQ2 current at t=0. (C) Extracellular application of 1 mM neomycin (orange circles) did not affect KCNQ2 current compared with the control (open circles). (D) Histogram depicting KCNQ2 currents at t=10 min showing that both diC4-PIP2 and diC8-PIP2 are equally effective to restore KCNQ2 current rundown induced by neomycin. Values for control, intracellular neomycin and diC4-PIP2 are from (B, C). NS: not significant, *** 0.05, paired t-test), while KCNQ2 (S541D) showed 1.7-fold increase (** <0.01, paired t-test), suggesting that endogenous PIP2 is not at saturating concentration for KCNQ2 (S541D). (G) Calmodulin binding of other KCNQ2 mutants including KCNQ2 (R353G) and KCNQ2 (S534D) compared with that of KCNQ2 (wt). (H) Dose response curve for neomycin of KCNQ2 (R353G) overlaid to that of KCNQ2 (wt) shown in (E) (grey circles). (I) KCNQ2 (R353G) (green circles) showed hyperreactivity to 0.1 μM oxo-M. Oxo-M response of KCNQ2 (S541D) shown in Figure 1D is also shown as a reference (shaded blue circles). Error bars indicate s.e.m. Download figure Download PowerPoint Next, we measured dose-responses for neomycin at 10 min time points after rupturing the membrane (Figure 4E). Wild-type and KCNQ2 (S541A) showed similar neomycin inhibition curves (see Supplementary Figure 1 for IC50 and Hill coefficients). In contrast, KCNQ2 (S541D) exhibited a higher sensitivity to neomycin, suggesting lower PIP2 affinity (Figure 4E, blue circles). To directly examine whether these channels have different PIP2 sensitivity, we included 500 μM diC8-PIP2 in the patch pipette solution and measured current augmentation 2 min after rupturing the plasma membrane (Figure 4F). Wild-type and KCNQ2 (S541A) did not show increase in current by diC8-PIP2, suggesting that endogenous PIP2 is at a saturating concentration. On the other hand, KCNQ2 (S541D) showed a 1.7±0.4 fold increase (n=17, P<0.01 paired t-test). These results suggest that PKC phosphorylation of S541 can change not only calmodulin binding, but also the interaction with PIP2. One remaining critical question is whether this change in PIP2 affinity is due to the reduced calmodulin binding or the conformational changes that are introduced into the cytoplasmic tail of the KCNQ2 subunit as a result of mutations at position S541. In order to resolve this important question, we analysed another calmodulin-deficient mutant, KCNQ2 (R353G), which has been identified in patients with benign familial neonatal convulsions (Etxeberria et al, 2008). As previously reported, KCNQ2 (R353G) exhibited a reduced current density compared with that of wild-type (15±1.3 pA/pF, n=57) and reduced calmodulin binding compared with wild-type KCNQ2 channel (Figure 4G) (Etxeberria et al, 2008). Electrophysiological measurements using this mutant revealed an increased sensitivity towards neomycin, which was similar to that of KCNQ2 (S541D) (Figure 4H; Supplementary Figure 1; n=6). Interestingly, KCNQ2 (R353G) showed a hypersensitivity to oxo-M in a manner that was similar to the KCNQ2 (S541D) channel mutant (Figure 4I; n=9, P<0.05 compared with KCNQ2 (wt) shown in Figure 1D). These results show that distinct mechanism for disturbed calmodulin binding can result in similar PIP2 phenotype. One interpretation of these findings is that KCNQ2–calmodulin binding determines PIP2 affinity. However, these findings could be coincidence since observations were made with two mutants. To further minimize the risk of relating coincidental events, we analysed KCNQ2 (S534D), a secondary PKC phosphorylation site with a milder phenotype (Hoshi et al, 2003) (Figure 4G). Scattered plots from these mutants showed strong correlations among KCNQ2–calmodulin binding, IC50 for neomycin and fold increase by diC8-PIP2 (Supplementary Figure 1). These results indicate that KCNQ2–calmodulin binding is closely related with PIP2 affinity. PKC phosphorylation and muscarinic stimulation lower affinity towards PIP2 Since the KCNQ2 (S541D) phosphomimetic mutant enhances neomycin induced rundown of the current, we examined whether activation of cellular PKC can reduce the affinity of wild-type channel towards PIP2. KCNQ2-expressing cells were stimulated by phorbol-12,13-dibutyrate (PDBu) to activate PKC. To our surprise, 100 nM PDBu application alone had no effect on the KCNQ2 current in this condition (Figure 5A; n=12). Likewise, 100 μM neomycin alone had little effect on the KCNQ2 current (Figure 5B, open circles; n=14). When these two treatments were combined, however, application of PDBu could suppress KCNQ2 current (Figure 5B, black circles; n=14). This suggests that PKC-phosphorylated KCNQ2 channel becomes more sensitive to a reduction in the availability of PIP2 (Figure 5B and C). In contrast, KCNQ2 (S541A) channel did not show PDBu induced suppression even in the presence of neomycin, which suggests that PKC phosphorylation of S541 is key for this suppression (Figure 5C). Figure 5.Activation of PKC sensitizes KCNQ2 current to sequestering of PIP2 by neomycin. (A) PDBu application onto wild-type KCNQ2 current had little effect. The black box indicates the presence of 100 nM PDBu. (B) PDBu application induced current suppression of wild-type KCNQ2 current when neomycin was included in the patch pipette solution. (C) Relative KCNQ2 current amplitudes at t=2 min from KCNQ2 (wt) without neomycin shown in (A) (left), in the presence of neomycin, Neo Q2 (wt), shown in (B) (middle), and KCNQ2 (S541A) in the presence of neomycin (right). **<0.01 nonparametric ANOVA followed by t-test. Error bars indicate s.e.m. Download figure Download PowerPoint The next logical question was whether muscarinic stimulation decreases PIP2 affinity of the KCNQ2 channel. To test this hypothesis we used a metabolically stable PIP2 derivative, ms-PIP2, which is resistant to hydrolysis by PLC. We reasoned that if muscarinic suppression is exclusively mediated by PIP2 depletion, the stable ms-PIP2 derivative would sustain channel activity. Exchange of endogenous PIP2 for ms-PIP2 was favoured by maintaining a lower concentration of ATP (1 mM) in the patch pipette solution (Supplementary Figure 2). With 1 mM ATP in the pipette solution, KCNQ2 current showed significant rundown, which was prevented by higher ATP (4 mM) or further addition of 500 μM ms-PIP2 or 500 μM diC4-PIP2 in the pipette solution (Supplementary Figure 2). These results suggest that active KCNQ2 currents with 1 mM ATP in the pipette solution are maintained by exogenous PIP2. We examined muscarinic suppression of KCNQ2 currents in the presence of ms-PIP2 using 0.3 μM oxo-M. The wild-type KCNQ2 channel showed equivalent muscarinic suppression in both control (4 mM ATP) and ms-PIP2 supplemented condition (Figure 6A; n=11). The KCNQ2 (S541A) mutant, on the other hand, showed reduced muscarinic suppression compared with that of wild type (Figure 6B, open circle; n=10). Importantly, muscarinic suppression of KCNQ2 (S541A) was further attenuated in the presence of ms-PIP2 (Figure 6B and C; n=9). This implies that depletion of PIP2 serves as a dominant mechanism when the KCNQ2 subunit is not phosphorylated at Ser 541. Figure 6.PKC phosphorylation sensitizes KCNQ2 channel and M-channel for reduction of PIP2 during muscarinic stimulation. (A) A PLC-resistant PIP2 analogue, ms-PIP2, did not disrupt oxo-M responses of wild-type KCNQ2 channel recorded by whole-cell patch clamp. The black box indicates the presence of 0.3 μM oxo-M. (B) Ms-PIP2 disrupted oxo-M responses of KCNQ2 (S541A) channel. (C) Pooled data of normalized KCNQ2 current at t=1 min from (A, B) showing that exogenous ms-PIP2 had no effects on wild-type KCNQ2 channel in response to oxo-M. But for KCNQ2 (S541A) channel, ms-PIP2 attenuated the oxo-M response. **<0.01 by nonparametric ANOVA followed by t-test. (D) Whole-cell pat
Referência(s)